Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/05/067570
CTRI/2024/05/067570
Not yet recruiting
未知

A descriptive study to assess the risk of cardiovascular diseases in Spinal Cord Injury patients above 30 years of age. - NI

Dr Rushikesh Eknath Kalwaghe0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Rushikesh Eknath Kalwaghe
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Dr Rushikesh Eknath Kalwaghe

Eligibility Criteria

Inclusion Criteria

  • •1\. Person with spinal cord injury (traumatic and non\-traumatic).
  • •2\. A person with spinal cord injury of both sexes.
  • •3\. Above 30 years of age.
  • •4\. Duration of spinal cord injury more than 6 months.

Exclusion Criteria

  • •1\. Age below 30 years,
  • •2\. Traumatic brain injury,
  • •3\. Stroke history,
  • •4\. Pregnant women
  • •5\. Amputation
  • •6\. History of diabetes mellitus and/or hypertension before Spinal cord injury
  • •Duration less than 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Study to Determine if The Cardiovascular risk indices in Impaired Glucose Tolerance are similar for Polycystic Ovarian Syndrome, and whether they may be modified by Therapy - Cardiovascular risk in PCOS as compared to impaired glucose toleranceThis is a randomised parallel controlled trial between patients with impaired glucose tolerance and those with polycystic ovarian syndrome. Patients will either be randomised to metformin or Pioglitazone.
EUCTR2005-000435-18-GBniversity of Hull48
Active, not recruiting
Phase 1
Study to Determine if The Cardiovascular risk indices in Type 2 diabetes are similar for Polycystic Ovarian Syndrome, and whether they may be modified by Therapy - Cardiovascular risk in PCOS as compared to type 2 DiabetesThis is a randomised parallel controlled trial between patients with type 2 diabetes and those with polycystic ovarian syndrome. Patients will either be randomised to metformin or Pioglitazone.
EUCTR2005-000461-18-GBniversity of Hull48
Recruiting
Not Applicable
Exploratory study on the evaluation of cardiovascular care structure and quality in the cardiovascular network of BavariaCardiac DiseaseHeart valve defectAortic diseaseI20-I25I50.9I42I40I49.9Q24I51.4I71Ischaemic heart diseasesHeart failure, unspecifiedCardiomyopathyAcute myocarditisCardiac arrhythmia, unspecifiedOther congenital malformations of heartMyocarditis, unspecifiedAortic aneurysm and dissection
DRKS00033468niversitätsklinikum Augsburg828
Recruiting
Not Applicable
A prospective study for assessment of cardiovascular risk in polycystic ovarian syndromeEndocrine, nutritional and metabolic disease
KCT0000092Ewha Womans University350
Not yet recruiting
Not Applicable
A study of cardivascular risk in type 2 diabetes mellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2019/08/020792Dr Arshiya